Previous Close | 0.5500 |
Open | 0.4100 |
Bid | 0.1900 |
Ask | 0.6800 |
Strike | 310.00 |
Expire Date | 2025-01-17 |
Day's Range | 0.4100 - 0.4700 |
Contract Range | N/A |
Volume | |
Open Interest | 1.37k |
Moderna ( NASDAQ:MRNA ) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91% from 1Q 2023...
Despite a significant revenue drop, Moderna showcases robust clinical progress and strategic collaborations.
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.